Latest news

Tuberculosis and HIV

More intensive screening for TB needed for HIV-positive patients in South Africa

Many cases of tuberculosis (TB) in patients starting HIV therapy will be missed if screening for the disease relies on 2006 World Health Organization (WHO) guidelines, investigators from South Africa report in ...

Published

5 hours ago

By

Michael Carter

New

PEP

Truvada/Kaletra HIV PEP combination is safe and effective with a low rate of discontinuations

A post-exposure prophylaxis (PEP) combination of FTC/tenofovir (Truvada) with lopinavir/ritonavir (Kaletra) tablets is safe and generally well-tolerated, French investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The ...

Published

7 hours ago

By

Michael Carter

New

Delivery of care

Loss to follow-up high in South African public sector ARV programmes

Almost thirty per cent of patients who started antiretroviral treatment in eight South African public sector programmes were lost to follow-up within three years, according to a cohort analysis published in the online ...

Published

08 September 2010

By

Carole Leach-Lemens

Vaccines

Where is HIV vaccine research heading?

Following last year’s positive result from an HIV vaccine trial in Thailand the Global HIV Vaccine Enterprise has issued a new scientific plan, calling for a speeded-up effort to test new vaccine candidates ...

Published

08 September 2010

By

Keith Alcorn

Treatment as prevention

High genital HIV levels may persist in women who appear to achieve viral suppression with use of ART

HIV-positive women whose plasma HIV RNA viral loads drop to undetectable levels following initiation of ART still may have intermittent surges in the amount of virus in their genital secretions, according to a ...

Published

06 September 2010

By

Kelly Safreed-Harmon

Cancer

Recurrent pneumonia increases lung cancer risk for patients with AIDS

Recurrent bacterial pneumonia is associated with an increased risk of lung cancer in patients with AIDS, US investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The association ...

Published

06 September 2010

By

Michael Carter

Kenyan study shows people with HIV can provide safe, effective community management of ART

Community-based care delivered to adults living with HIV by people living with HIV using mobile technologies provided care as safe and effective as clinic-based care, researchers report in the advance online edition of ...

Published

02 September 2010

By

Carole Leach-Lemens

Clinical trials

Imiquimod a good treatment for pre-cancerous anal lesions in men with HIV

HIV treatment centres should screen and treat pre-cancerous anal lesions, UK investigators argue in the online edition of AIDS. They were prompted to make this suggestion by research showing that treatment with imiquimod cream ...

Published

02 September 2010

By

Michael Carter

Policy and planning

People with HIV with higher CD4 counts should not miss seasonal flu jabs

HIV-positive patients with a CD4 cell count below 350 cells/mm3 have an impaired immune response to the seasonal influenza (flu) vaccine, Swiss investigators report in the September 10th edition of AIDS. They recommend ...

Published

01 September 2010

By

Michael Carter

Treatment for women

Nevirapine toxicity in women predicted by liver function, not CD4 count, developing country study reports

Abnormal liver function tests at baseline, not CD4 cell counts over 250 cells/mm³, were predictors for severe liver damage and associated rash researchers among women in Zambia, Thailand and Kenya on a nevirapine-based antiretroviral ...

Published

01 September 2010

By

Carole Leach-Lemens